Pfizer Inc. News
Stock Market Today - 6/30: Stocks End Lower as Powell Warns of 'Pain' Required to Tame Inflation
Global central bankers aren't taking their foot from the rate hike pedal, even if its means near-term recession, and that has stocks facing their worst start to the year since 1970.
Pfizer Stock Jumps On $3.2 Billion U.S. Covid Vaccine Sale, FDA Paxlovid Approval Filing
“As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.
Birth Control Stocks May Benefit From the Reversal of Roe v. Wade
The historic Supreme Court decision may force women to make different choices.
Microsoft-Developed Covid Tech Can Now Detect Lyme Disease
Adaptive Biotech's T-Detect Lyme was created by combining Azure cloud computing and sequencing of the immune system.
Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?
Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning.
Morningstar's Five Coping Mechanisms for Bear Market
The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?
Economist Roubini: Why Stocks Poised for 50% Wipeout
The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.
Micron Earnings Preview: Will Critical Support Hold?
Micron is set to report earnings on Thursday after the close, but the stock sits on critical support. Will it hold or will it fold?